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Abstract
Chylomicron particles are continually synthesised and secreted from the intestine even in the absence of ingested fat. It is possible that following consump-
tion of low doses of fat the basal level of chylomicron secretion and subsequent metabolism are sufficient to metabolise this fat without an increase in
postprandial chylomicron concentrations. To test this hypothesis, healthy male subjects were randomised to receive, on three separate occasions, meals
containing a range of doses of fat (average 8·1–19 g) and effects on postprandial lipaemia and chylomicron concentration were determined.
Furthermore, to delineate the effect on lipid-rich v. lipid-poor (remnant) forms lipid levels were also determined in a density <1·006 g/ml fraction.
Following consumption of the very low dose of fat the postprandial concentration of chylomicrons was unaltered, whereas following the medium dose
postprandial chylomicron concentrations were significantly increased. Interestingly, this increase was only detected in the lipid-rich chylomicron fraction,
with postprandial levels of chylomicron remnants remaining unchanged. In conclusion, it appears that consumption of what would be considered low to
medium doses of fat are not associated with transient postprandial increases in chylomicron remnants in healthy male subjects.
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Introduction
Impaired postprandial lipid metabolism as a risk factor for
CVD is an area that has attracted great interest since the
hypothesis was highlighted by Zilversmit in 1979(1). Given
that we spend the majority of our life in a postprandial state
an understanding of the regulation of postprandial lipid metab-
olism is important. A number of studies have focused on the
regulation of postprandial TAG and the results have helped
establish elevated postprandial TAG concentrations as an
independent risk factor for CVD(2). Elevations in postprandial
TAG concentrations result from a combination of increased
concentration of TAG-rich chylomicron and VLDL particles,
and their remnants. Such elevations appear to result from
increased competition for lipolysis and particle clearance path-
ways due to the increased secretion of TAG-rich chylomicrons
by enterocytes. However, postprandial remnant lipoproteins
have also been established as a risk factor for atherosclerosis
and CVD and it is therefore important to examine factors
affecting their concentration. Following hydrolysis by endo-
thelial lipases, TAG-depleted chylomicrons, secreted by the
intestine in response to dietary fat and, thereafter, hepatically
derived VLDL remnants attain a sufficiently small diameter
to become entrapped within the sub-endothelial space(3).
Chylomicron and VLDL remnants contain twenty–forty
Abbreviations: LBM, lean body mass; iAUC, incremental area under the curve.
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times more cholesterol per particle compared with LDL and
initiate a powerful cytokine response when retained within
the arterial intima. Moreover, these remnant lipoproteins are
avidly degraded by macrophages, initiating a respiratory burst
and exacerbating endothelial oxidative stress(4,5).
One of the factors that could be expected to be important in
determining the extent and duration of postprandial lipaemia is
the dose of lipid consumed in a test meal. Indeed, it has been
reported that a stepwise increase in the postprandial serum
TAG response results with increasing amount of fat con-
sumed(6,7). A threshold ingestion of about 15 g is ordinarily
required to induce transient lipaemia in otherwise healthy
lean individuals. Consumption of other macronutrients, in par-
ticular carbohydrates, as well as the type of fatty acids may also
confer some regulation of postprandial lipaemia, the former
via insulin-regulated pathways(8). However, due to differences
in regulation of the lipolysis and clearance pathways it is poss-
ible that elevated postprandial lipaemia may not always track
directly with levels of remnant lipoproteins. It is important
therefore to determine the effect of dietary lipid load on arter-
ial exposure to the post-hydrolysed pro-atherogenic remnant
lipoproteins. Remnant lipoproteins, being smaller in size
than their TAG-rich progenitors, are able to penetrate arterial
tissue(3), and induce macrophage lipid loading(9–11). The deter-
mination of remnant lipoproteins in the postprandial state is
therefore of importance in evaluating the atherogenic risk of
postprandial lipaemia. It is likely that accumulation of rem-
nants of both hepatic and intestinal origin plays an important
role in the initiation and progression of atherosclerosis and
vascular inflammation(12). Determination of the concentration
of chylomicron particles can be done by measurement of
apoB48 concentration in the circulation. More importantly,
elevated apoB48 concentrations both in fasting and postpran-
dial states have been reported in obese subjects(13) and in type
1 and type 2 diabetics(14,15).
Chylomicron particles appear to be constitutively syn-
thesised and secreted by enterocytes(16,17) even in the absence
of ingested fat. Results from animal and clinical studies suggest
that, unlike hepatically derived TAG-rich VLDL, basal rates of
chylomicron biosynthesis are chronically modulated and not
significantly influenced by singular meals containing fat. In
rats, following lipid infusion there was only a 1·5-fold increase
in the rate of chylomicron particles secreted; whereas the
size of secreted lymph chylomicrons was up to 13·8-fold
greater(17). Furthermore, in free-living subjects we have pre-
viously observed that the basal circulating concentration of
chylomicrons represent approximately 70% of the peak levels
attained throughout the day(18). It appears therefore that the
basal synthesis of chylomicrons can accommodate most of
the lipid absorbed from meals by the formation and secretion
of larger, lipid-rich chylomicrons. However, it remains unclear
whether the extent of nascent chylomicron lipidation within
the enterocyte subsequently influences plasma metabolism of
chylomicrons, or thereafter interaction and kinetics within
the arterial intima. Indeed, the atherogenic risk associated
with postprandial lipaemia may primarily be indicative of
chronic disturbances in chylomicron remnant homoeostasis,
rather than reflecting single and transient meal effects. To
explore this hypothesis further, healthy male subjects were
randomised to receive, on three separate occasions, meals con-
taining a range of very low to medium doses of fat (average
8·1–19 g) and effects on postprandial lipaemia and chylomi-
cron concentration were determined.
Experimental methods
Subjects
A total of ten healthy normolipidaemic (TAG < 1·7 mM) gen-
erally lean male subjects were recruited. Exclusion criteria
included smoking within 2 years prior, liver or endocrine
dysfunction, malabsorption syndrome, anaemia, hypothyroid-
ism, and the use of lipid-lowering or hypertensive agents.
Diabetes was excluded based on fasting serum glucose being
less than 7 mM. Informed consent was obtained from all sub-
jects. This study was conducted according to the guidelines
laid down in the Declaration of Helsinki and all procedures
involving human subjects/patients were approved by the
Curtin University Human Research Ethics Committee (HR
95/2007). Written informed consent was obtained from all
subjects. The study is registered with the Australian New
Zealand Clinical Trials Registry (ACTRN12611000795998).
Design
The study was a randomised crossover design where the sub-
jects were required to attend three postprandial testing days.
On each of these testing days the subjects were given a
milkshake to consume containing either a very low, low, or
medium dose of fat (0·15, 0·25 and 0·35 g/kg lean body
mass (LBM)). The time between each of the three testing
days was between 2 and 4 weeks.
Diet standardisation
As there is evidence that a subject’s preceding diet affects post-
prandial lipaemia(19,20) and to ensure that the subjects were in a
basal metabolic state prior to consuming each of the postpran-
dial test meals, low-fat standard meals were given to consume
on the evening prior to each test day. The standardised eve-
ning meal was consumed prior to 20·00 hours after which
no other food or drinks (other than water) were consumed.
The foods consumed prior to their first visit were replicated
exactly on all subsequent visits. These foods consisted of
low-fat frozen meals, yoghurt, orange juice and muesli bars.
The average composition of these meals was: energy 3273 kJ,
protein 32 g, fat 13 g (saturated 6·8 g, cholesterol 38·4 mg),
carbohydrate 125 g (sugars 53·4 g)
Determination of lean body mass
LBM was determined using a lunar prodigy DPX-L
dual-energy X-ray machine (Lunar Corp.) with Encore 2004
analysis software version 8·50. A whole body scan was per-
formed once prior to commencement of the first postprandial
test day. The subjects were scanned in a standard cotton gown
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and the positioning of the subjects was done according to stan-
dard procedure. In addition, prior to each scan a calibration
check was done using the spine phantom provided by the
manufacturer. The CV for LBM was previously determined
as 0·5%(21).
Postprandial lipoprotein assessment
The subjects arrived at the clinical rooms for their postprandial
test days at about 08.00 hours after having fasted for at least
12 h. Upon arrival, the subject’s body weight, height, waist
and hip circumference were measured following the standar-
dised procedures and using a single trained observer.
A fasting blood sample was collected after the subjects were
relaxed and had sat upright for 5 min. Following the blood
sample the subjects were given their milkshake and asked to
consume it within 1–2 min. To ensure that all of the milkshake
was consumed, the cup was rinsed extensively with water
which was then consumed. The postprandial test drink con-
sisted of whipping cream (variable amount), chocolate flavour-
ing (1 g) and water (100 ml) only. The amount of cream was
calculated for each volunteer based on their LBM (determined
by dual-energy X-ray) to ensure the fat content of the drink
was 0·15, 0·25 and 0·35 g/kg LBM for the very low, low
and medium test drinks, respectively. The average nutritional
composition of the test meals was: very low (8·1 g fat, 1·6 g
carbohydrate and 0·4 g protein); low (13·6 g fat, 2·0 g carbo-
hydrate and 0·7 g protein); medium (19·0 g fat, 2·5 g carbo-
hydrate and 1·0 g protein).
After consumption of the milkshake venous blood samples
were collected at the following time points: 45, 90, 150 and
240 min. Blood samples were collected in vacuum tubes con-
taining either clotting activators for isolation of serum, EDTA
for isolation of plasma and EDTA with fluoride salt for iso-
lation of plasma for glucose determinations. Samples for
serum isolation were left to clot prior to centrifugation at
approximately 2000 g for 10 min at 4°C. Aliquots of plasma
and sera were collected and stored at −80°C before sub-
sequent analysis. The subjects remained mostly confined to
the clinical room during the study apart from bathroom access
and mostly read, or did computer-based work. The subjects
were offered water and green/black tea (without milk or
sugar) during the postprandial period; however, consumption
times and levels were recorded and replicated on each test day.
VLDL (density <1·006 g/ml) fractions were collected
following ultracentrifugation of plasma samples. A density sol-
ution (1·006 g/ml) prepared as described by Havel et al.(22)
was overlayed on 1 ml of plasma in 5 ml thin-walled tubes
(Thermo Scientific). The samples were then spun at 40 000
rpm for 21 h at 18°C using an AH-650 swing-out rotor
(Thermo Scientific). Following ultracentrifugation the lipopro-
tein fraction was collected by aspiration and immediately
stored at −80°C prior to analysis.
Lipid, insulin and glucose assays
Serum TAG, cholesterol, glucose and insulin were determined
by Pathwest Laboratories using their routine automated
procedures on an Architect c1600 analyser. Briefly, TAG,
total cholesterol, HDL-cholesterol and glucose were deter-
mined using specific enzyme-based colorimetric reagents
(Abbott Diagnostics; CV < 2%) LDL-cholesterol was esti-
mated using a modified version of the Friedewald equation(23).
Insulin was determined by Pathwest Laboratories using an
Immulite 2000 Insulin Analyser (Siemens Medical Solutions
Diagnostic; CV < 5%). NEFA were determined using the
Wako NEFA C kit (Wako Pure Chemical Industries Ltd)
according to the manufacturer’s instructions.
The lipid-rich fraction was assayed directly for TAG and
cholesterol using the same methods described for serum
samples, their concentration was then expressed relative to
that arising from 1 ml of plasma.
apoB determination
apoB48 concentration was determined using a commercial
sandwich ELISA method using a monoclonal antibody raised
against the C-terminal region of apoB48 (Shibayagi Human
apo B-48 ELISA Kit). For details of the method validation,
refer to Kinoshita et al.(24). Serum samples collected during
the postprandial tests were analysed according to the manu-
facturer’s instructions with the exception that samples were
diluted 1 in 200 to ensure that the raised postprandial
apoB48 concentrations remained within the standard curve.
Determination of apoB48 in the lipid-rich fractions was per-
formed as described for the serum samples, and was also
done with a dilution of 1 in 200 prior to assay. Concentrations
of apoB48 in the lipid-rich fraction were expressed relative
to that arising from 1 ml of plasma. The concentration of
apoB48 in the infranatant fraction (density >1·006 g/ml) was
calculated by subtracting the concentration of apoB48 in the
lipid-rich fraction from the total serum apo B48 concentration.
apoB concentration in the lipid-rich fraction was determined
using a commercial sandwich ELISA method (Abcam apo B
Human ELISA Kit) according to the manufacturer’s instruc-
tions with the exception that lipoprotein fractions were diluted
1 in 1000 prior to assay. The apoB content of the fraction was
then expressed relative to that arising from 1 ml of plasma.
Quantification of postprandial metabolism
Postprandial metabolism was quantified by calculating the area
under the curve (AUC) using the trapezoid method. However,
in order to standardise for fasting levels, AUC comparisons
between different doses of fat were corrected for the fasting
level of each parameter in both the statistical comparisons
and pictorially and hence represent incremental AUC (iAUC).
Statistical analysis
Analysis of the changes in baseline measures between visits
was done by univariate general linear modelling, whereas
changes in postprandial measures were assessed by comparing
the AUC for each parameter using univariate general linear
modelling with the fasting level of that parameter as a covariate
for each dose of fat given. All statistics were performed using
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SPSS Statistics version 17 (SPSS Inc.). Significance was
accepted at the P < 0·05 level and data are presented as
mean values with their standard errors.
Results
Subject characteristics and diet
The subject characteristics at baseline (first postprandial visit)
are shown in Table 1. The subjects were on average lean (range
21·6–25·6 kg/m2), normotensive, normoglycaemic and gener-
ally normolipidaemic. The subjects’ weight and other anthro-
pometric measurements were checked at each visit and did
not vary significantly throughout the course of the study
(data not shown), suggesting that they complied with our
request to maintain their normal diet and exercise throughout
the study.
Postprandial TAG
Following consumption of the very low dose of test milkshake
serum TAG concentrations remained relatively unchanged
with no significant difference compared with baseline
(Fig. 1). Consumption of the low dose of test milkshakes
resulted in a gradual increase in serum TAG concentrations,
reaching a peak concentration at 150 min (P < 0·05) before
decreasing towards baseline concentrations at 240 min
(Fig. 1). Similarly the TAG response following the medium
dose of lipid gradually increased and was significantly raised
at 150 min (P< 0·001) and remained elevated at 240 min (P
< 0·05, Fig. 1). Quantification of the postprandial TAG
response to each dose of milkshake was determined by calcu-
lating the areas under the postprandial TAG curves (corrected
for baseline levels, iAUC). The postprandial response to the
medium-fat load milkshake was significantly greater (267%,
P < 0·05) than that observed following the very-low-fat-load.
Whereas the response following the low-fat-load milkshake
was not different from that observed following either the
very-low- or medium-fat loads (Fig. 1).
The concentration of TAG was also determined in the
lipid-rich fraction encompassing both VLDL particles and
chylomicron particles (density >1·006 g/ml). Following
consumption of the very-low-fat load the TAG concentration
in the lipid-rich fraction remained relatively unchanged, with
no significant difference compared with the baseline concen-
tration (Fig. 1). The TAG concentration, however, tended to
increase postprandially, significantly greater or approaching
significance in the later stages following the medium- and
low-fat loads, respectively (Fig. 1). However, despite this the
iAUC for TAG in the lipid-rich fraction was not significantly
different between the fat loads (Fig. 1).
The concentration of TAG in the lipid-poor fraction
(density >1·006 g/ml) was calculated by subtracting the con-
centration of TAG in the lipid-rich fraction (density <1·006
g/ml) from the total TAG concentration in serum. The lipid-
poor fraction was taken to represent a small remnant fraction
encompassing lipid-depleted lipoprotein remnants of intestinal
and hepatic origin. Following consumption of each fat load,
however, the TAG concentration was essentially unchanged
and quantification of the iAUC for TAG in this remnant frac-
tion revealed no significant difference in response between the
fat loads (Fig. 1).
Postprandial apoB48
Following consumption of both the very low and low doses of
test milkshake no significant changes in serum chylomicron
concentration (measured by apoB48) were observed (Fig. 2).
Consumption of the medium dose of test milkshake, however,
resulted in significant changes in serum chylomicron concen-
tration, with levels of apoB48 gradually increasing, reaching
a peak concentration at 150 min (P< 0·01) before decreasing
towards baseline concentrations at 240 min (Fig. 2). The post-
prandial chylomicron response as determined by the areas
under the postprandial apoB48 curves (corrected for baseline
levels, iAUC) varied among the different fat loads. The iAUC
following the very-low-fat-dose milkshake was negative, indi-
cating chylomicron concentration remained essentially at or
below baseline concentrations for 240 min following the
meal. A positive iAUC was observed following the low and
medium doses of fat, and the response following the medium
dose of fat was significantly (P < 0·05) greater than that
observed following the very-low-dose meal. Whereas the
response following the low fat dose milkshake was not differ-
ent from that observed following either the very-low- or med-
ium-fat-dose milkshakes.
The concentration of chylomicron particles in the lipid-rich
fraction did not change significantly following the very low or
low doses of fat load; however, it gradually increased following
the medium dose of fat load, with apoB48 concentration
remaining significantly higher than baseline levels at 90 and
150 min (P < 0·01) before returning to baseline levels at 240
min (Fig. 2). Quantification of the iAUC for apoB48 in this
lipid-rich fraction revealed a sequentially greater response as
the dose was increased, with the iAUC following the low-
and medium-dose-fat milkshakes being significantly greater
(205 and 500 %, respectively; P < 0·05) than that observed fol-
lowing the very-low-dose milkshake, and the iAUC following
the medium-dose-fat load was greater (97 %, P < 0·05) than
that observed following the low-dose milkshake (Fig. 2).
Table 1. Baseline subject characteristics determined at the first visit
(Mean values with their standard errors)
Characteristic Mean SE
Age (years) 33·4 4·2
Weight (kg) 72·1 2·2
Lean mass (kg) 54·2 2·1
BMI (kg/m2) 24·0 0·4
Waist circumference (cm) 84·2 2·1
Waist:hip 0·86 0·02
Systolic blood pressure (mmHg) 120·1 3·9
Diastolic blood pressure (mmHg) 74·8 2·0
Total cholesterol (mM) 5·1 0·4
LDL (mM) 3·3 0·4
HDL (mM) 1·3 0·07




In order to estimate the effects of the fat load on postpran-
dial small chylomicron remnant concentrations the concen-
tration of apoB48 in the lipid-poor fraction (density >1·006
g/ml) was calculated by subtracting the concentration of
apoB48 in the lipid-rich fraction (density <1·006 g/ml) from
the total apoB48 concentration in serum. Following consump-
tion of each fat load, however, the apoB48 concentration was
essentially unchanged and quantification of the iAUC for
apoB48 in this remnant fraction revealed no significant differ-
ence in response between the fat loads.
Changes in other postprandial measures
The postprandial glucose response following all three fat loads
was essentially the same, with a rapid reduction in glucose con-
centrations which remained suppressed up to either 90 or 150
min (Fig. 3; P< 0·05) before returning to baseline levels at
240 min postprandially. The postprandial iAUC for glucose
was not different between the fat loads (Fig. 3). The postpran-
dial insulin response to the different fat loads was varied; the
response following the very low and low doses was similar,
with a general reduction in insulin levels persisting at 240
min (Fig. 3; P < 0·01). Following the medium dose of fat insu-
lin initially increased at 45 min (P< 0·001) before returning,
and remaining, at baseline levels (Fig. 3). As a result the post-
prandial iAUC for insulin following the medium dose of fat
was significantly greater than that observed following the
very low dose (Fig. 3; P< 0·05). The postprandial NEFA
response following each fat load was essentially identical,
with a gradual increase in NEFA concentration postprandially
reaching significantly elevated levels at 240 min (Fig. 3; P <
0·001). Indeed there were no significant differences in the
postprandial responses (iAUC) between the different fat
loads (Fig. 3).
In order to assess changes in VLDL particle number the con-
centrations of apoB and cholesterol were determined in the
lipid-rich fraction. However, there were no significant changes
in these measures following or between the different fat loads.
The areas under the postprandial curve for cholesterol were
0·87 (SE 0·44), 0·88 (SE 0·54) and 0·93 (SE 0·33) mM × h
and those for apoB were 12·5 (SE 0·9), 13·5 (SE 0·9) and 12·3
(SE 0·9) μM × h following the very low, low and medium
meals, respectively.
Discussion
In the present study, we examined the effects of consumption
of a range of generally low doses of fat on postprandial chylo-
micron metabolism. Following consumption of the medium
dose of fat significant increases in the circulating concentration
of chylomicron particles (apoB48) were observed, whereas the
very low dose did not result in any postprandial change in
Fig. 1. Postprandial concentrations of TAG. Concentrations of TAG in serum (A), VLDL fraction (B) and infranatant (C) in the fasting state (0 min) and for 240 min
after consumption of the very low (○), low (•) and medium (▵) test meals. Quantification of the postprandial TAG response in serum (D), lipid-rich fraction (E) and
lipid-poor fraction (F), shown as area under the curve AUC (corrected for baseline levels, incremental AUC (iAUC)). Values are means, with standard errors rep-




apoB48 concentration. It appears therefore that the basal rate
of chylomicron synthesis, lipolysis and clearance is sufficient to
metabolise the very low doses of fat ingested without an
elevation in postprandial chylomicron concentration resulting
in (Fig. 2). Indeed chylomicron particles appear to be constitu-
tively synthesised even in the absence of ingested fat, with
basal (fasting) levels being approximately 70 % of the peak
levels attained throughout the day in free-living subjects(18).
Once secreted into the circulation chylomicrons are rapidly
acted on by lipoprotein lipases prior to being cleared from
the circulation with a half-life of plasma residency time
between 5 and 15 min(25). We also observed that consumption
of the very low dose of fat did not result in a change in post-
prandial TAG concentrations, a finding previously reported by
Dubois et al.(7). This lack of effect on postprandial TAG con-
centrations again suggests that the rate of lipolysis and/or
clearance capacity is sufficiently high to process these low
levels of ingested fat (Fig. 1). Thus, it remains possible that
the basal rate of chylomicron synthesis may accommodate
low doses of ingested fat by an increase in chylomicron particle
size without the need for increased chylomicron particle syn-
thesis. However, following the consumption of the medium
dose of fat it appears that an increase in chylomicron synthesis
is required to accommodate the ingested fat and/or limitations
in the capacity of the lipolytic, and particle clearance pathways
result in a net accumulation of postprandial TAG and
chylomicron particles. Interestingly, although the consumption
of the low and medium doses of fat resulted in a significant
increase in the postprandial TAG concentration, it appears
that this effect was not localised in either the lipid-rich or lipid-
poor fractions (Fig. 1).
In the circulation chylomicron particles exhibit a fairly large
heterogeneity with respect to size, resulting from variations in
the amount of lipid incorporation during their enterocytic for-
mation, and the extent of lipolysis that has occurred in circula-
tion(26). However, in terms of atherogenic potential, it is only
the lipid-depleted remnant forms that are of a size sufficiently
small enough to penetrate arterial tissue(3), and induce macro-
phage lipid loading(9–11). But the quantification of chylomicron
remnants remains a difficult proposal due to the heterogeneity
of size. However, by determining the extent of circulating
chylomicrons that are of a density <1·006 g/ml (lipid-rich chy-
lomicrons), we can split the chylomicrons into those that are
lipid-rich and lipid-poor, the latter of which can be used as
a surrogate measure of the remnant particles which may be
small enough to permit transcytotic delivery to the sub-
endothelial space(3). Interestingly, the effect of increasing fat
load on chylomicron concentration appeared to be mostly
due to an increase in lipid-rich chylomicrons, with a stepwise
increase in postprandial apoB48 observed in the VLDL frac-
tion with increasing fat load, whereas the concentration of
lipid-poor chylomicrons was essentially unchanged following
Fig. 2. Postprandial concentrations of apoB48. Concentrations of apoB48 in serum (A), lipid-rich fraction (B) and lipid-poor fraction (C) in the fasting state (0 min) and
for 240min after consumption of the very low (○), low (•) and medium (▵) test meals. Quantification of postprandial apoB48 response in serum (D), lipid-rich fraction
(E) and lipid-poor fraction (F), shown as area under the curve (AUC) (corrected for baseline levels; incremental AUC (iAUC)). Values are means, with standard errors
represented by vertical bars. *Mean value was significantly different from that in the fasting state (P < 0·05). a,b,cMean values with unlike letters were significantly
different (P < 0·05).
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all doses of fat (Fig. 2). Hence, although consumption of
greater doses of fat results in sequentially greater circulating
chylomicron concentrations, the increase is due primarily to
an increase in lipid-rich chylomicron particles. It is possible
that these lipid-rich chylomicrons accumulate due to a limiting
rate of lipolysis and/or an increased chylomicron secretion;
however, once lipolysed the remnant forms (lipid-poor chylo-
microns) appear to be rapidly cleared from circulation and do
not accumulate. However, although no difference was detected
in the concentration of apoB48 in the lipid-poor fraction, it is
possible that greater doses of fat consumption or monitoring
the postprandial response beyond 4 h may reveal an accumu-
lation of lipid-poor chylomicron remnants. Interestingly, the
concentration of apoB and cholesterol in the lipid-rich fraction
did not change following any of the fat loads, suggesting that
the VLDL particle number was unaltered. As VLDL and chy-
lomicron particles compete for the same lipolytic pathway(27)
one may speculate that an increased secretion of lipid-rich chy-
lomicrons may have been the primary reason for their post-
prandial accumulation.
The oral fat loads used in the present study consisted predo-
minantly of lipid with only minor levels of protein and carbo-
hydrate (maximum: 2·9 g carbohydrate and 1·0 g protein),
mostly coming from the cream. The amount of added sugar
(in the form of chocolate flavouring) was kept constant across
the different fat loads. Consequently, protein and carbohydrate
content increased slightly with increasing dose of fat load. It is
likely that this is responsible for the increase in postprandial
insulin concentration observed following the medium fat
load. An increased postprandial insulinaemia has been
reported in some(7,28) but not all(29) studies examining post-
prandial effects of increased fat load. The slight changes in
insulin concentration observed in the present study in the
early postprandial phase appear to have been sufficient to
result in a suppression of postprandial glucose concentrations,
which, however, were not sufficient to significantly reduce
postprandial NEFA concentrations. Rather, NEFA concen-
tration increased towards the end of the postprandial period,
a finding that did not appear to be affected by the dose of
fat load given (Fig. 3). Others have reported either a similar
postprandial NEFA response or no effect of the dose of fat
on the postprandial NEFA response(28–30).
In conclusion, the findings in the present study show for the
first time that consumption of low doses of fat results in no
effect on the postprandial concentration of chylomicron par-
ticles. Rather, it appears that either the fat load is accommodated
by the basal level of chylomicron secretion, or the rate of lipo-
lytic, or clearance pathways are sufficient to rapidly process
slight fluctuations in chylomicron concentration. Following con-
sumption of moderate doses of fat the ensuing postprandial
chylomicronaemia appears to be primarily due to an accumu-
lation of lipid-rich chylomicron particles. Hence, in otherwise
Fig. 3. Postprandial concentrations of glucose, insulin and NEFA. Serum concentrations of glucose (A), insulin (B) and NEFA (C) in the fasting state (0 min) and for
240min after consumption of the very low (○), low (•) and medium (▵) test meals. Quantification of postprandial responses for glucose (D), insulin (E) and NEFA (F),
shown as area under the curve (AUC) (corrected for baseline levels; incremental AUC (iAUC)). Values are means, with standard errors represented by vertical bars.
*Mean value was significantly different from that in the fasting state (P < 0·05). a,bMean values with unlike letters were significantly different (P < 0·05).
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healthy male subjects the transient postprandial lipaemia
observed following consumption of moderate doses of fat is
not reflected by increased arterial exposure to pro-atherogenic
(lipid-poor) chylomicron remnants. However, in subjects with
remnant clearance disturbances, it is possible that acute lipid
meals may result in elevations in chylomicron remnant levels.
Furthermore, it remains to be determined whether consumption
of doses of fat greater than those used in the present study
would result in an accumulation of more lipid-poor remnant
chylomicron particles. The findings from the present study
raise the possibility that there is merit in limiting the amount
of fat consumed during mealtimes in order to reduce the circu-
lating concentration of pro-atherogenic (lipid-poor) chylomicron
remnants.
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